Brain Tumor Immunotherapy: What have We Learned so Far?

摘要: High grade glioma is a rare brain cancer, incurable in spite of modern neurosurgery, radiotherapy, and chemotherapy. Novel approaches are research, immunotherapy emerges as promising strategy. Clinical experiences with active specific demonstrate feasibility, safety most importantly, but incompletely understood, prolonged long-term survival fraction the patients. In relapsed patients, we developed an schedule categorized patients into clinically defined risk profiles. We learned how to combine standard multimodal treatment strategies for newly diagnosed glioblastoma multiforme The developmental program allows further improvements related newest scientific insights. Finally, mode care within academic centers organize cell-based therapies experimental clinical trials large number